HomeEKTA-B • STO
add
Elekta AB (publ)
Previous close
kr 56.75
Day range
kr 53.85 - kr 56.40
Year range
kr 40.64 - kr 66.70
Market cap
20.01B SEK
Avg Volume
1.23M
P/E ratio
-
Dividend yield
4.42%
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jan 2026info | Y/Y change |
|---|---|---|
Revenue | 4.24B | -9.71% |
Operating expense | 1.34B | 10.16% |
Net income | 10.00M | -97.07% |
Net profit margin | 0.24 | -96.69% |
Earnings per share | 0.88 | -6.38% |
EBITDA | 416.00M | -38.64% |
Effective tax rate | -500.00% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jan 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.54B | -29.08% |
Total assets | 27.68B | -16.01% |
Total liabilities | 19.67B | -11.11% |
Total equity | 8.01B | — |
Shares outstanding | 382.08M | — |
Price to book | 2.72 | — |
Return on assets | 2.50% | — |
Return on capital | 4.46% | — |
Cash Flow
Net change in cash
| (SEK) | Jan 2026info | Y/Y change |
|---|---|---|
Net income | 10.00M | -97.07% |
Cash from operations | 533.00M | -51.32% |
Cash from investing | -279.00M | 24.80% |
Cash from financing | -248.00M | 51.47% |
Net change in cash | -35.00M | -115.15% |
Free cash flow | 374.25M | -48.94% |
About
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. Elekta has a global presence in more than 120 countries, with over 40 offices around the world and about 4,700 employees. Wikipedia
Founded
1972
Website
Employees
4,438
